These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21443509)

  • 1. Cardiac effects of anabolic steroids: hypertrophy, ischemia and electrical remodelling as potential triggers of sudden death.
    Nascimento JH; Medei E
    Mini Rev Med Chem; 2011 May; 11(5):425-9. PubMed ID: 21443509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
    Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of androgenic-anabolic steroids in athletes.
    Hartgens F; Kuipers H
    Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases.
    Montisci M; El Mazloum R; Cecchetto G; Terranova C; Ferrara SD; Thiene G; Basso C
    Forensic Sci Int; 2012 Apr; 217(1-3):e13-8. PubMed ID: 22047750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do anabolic-androgenic steroids have performance-enhancing effects in female athletes?
    Huang G; Basaria S
    Mol Cell Endocrinol; 2018 Mar; 464():56-64. PubMed ID: 28711608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular side effects of anabolic-androgenic steroids].
    Kindermann W
    Herz; 2006 Sep; 31(6):566-73. PubMed ID: 17036188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in anabolic-androgenic steroids.
    Evans NA
    Am J Sports Med; 2004 Mar; 32(2):534-42. PubMed ID: 14977687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgenic anabolic steroid abuse and the cardiovascular system.
    Vanberg P; Atar D
    Handb Exp Pharmacol; 2010; (195):411-57. PubMed ID: 20020375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic elastic properties in athletes using anabolic-androgenic steroids.
    Kasikcioglu E; Oflaz H; Arslan A; Topcu B; Kasikcioglu HA; Umman B; Bugra Z; Kayserilioglu A
    Int J Cardiol; 2007 Jan; 114(1):132-4. PubMed ID: 16364476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.
    Frati P; Busardò FP; Cipolloni L; Dominicis ED; Fineschi V
    Curr Neuropharmacol; 2015 Jan; 13(1):146-59. PubMed ID: 26074749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.
    Achar S; Rostamian A; Narayan SM
    Am J Cardiol; 2010 Sep; 106(6):893-901. PubMed ID: 20816133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart disease induced by AAS abuse, using experimental mice/rats models and the role of exercise-induced cardiotoxicity.
    Riezzo I; De Carlo D; Neri M; Nieddu A; Turillazzi E; Fineschi V
    Mini Rev Med Chem; 2011 May; 11(5):409-24. PubMed ID: 21443510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.
    Nieschlag E; Vorona E
    Rev Endocr Metab Disord; 2015 Sep; 16(3):199-211. PubMed ID: 26373946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes.
    Hartgens F; Cheriex EC; Kuipers H
    Int J Sports Med; 2003 Jul; 24(5):344-51. PubMed ID: 12868045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anabolic androgenic steroids in amateur sports in the Netherlands].
    Woerdeman J; de Hon O; Levi M; de Ronde WP
    Ned Tijdschr Geneeskd; 2010; 154():A2004. PubMed ID: 20858322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a potential immune dysfunction with anabolic androgenic steroid use?: A review.
    Brenu EW; McNaughton L; Marshall-Gradisnik SM
    Mini Rev Med Chem; 2011 May; 11(5):438-45. PubMed ID: 21443507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal cardiac repolarization in anabolic androgenic steroid users carrying out submaximal exercise testing.
    Maior AS; Menezes P; Pedrosa RC; Carvalho DP; Soares PP; Nascimento JH
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1129-33. PubMed ID: 20880189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgenic-anabolic steroids abuse in males.
    Di Luigi L; Romanelli F; Lenzi A
    J Endocrinol Invest; 2005; 28(3 Suppl):81-4. PubMed ID: 16042364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Athletic Trainers' Association position statement: anabolic-androgenic steroids.
    Kersey RD; Elliot DL; Goldberg L; Kanayama G; Leone JE; Pavlovich M; Pope HG;
    J Athl Train; 2012; 47(5):567-88. PubMed ID: 23068595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.